CPRIT invested $63 million to bring innovative researchers and companies to Texas
On Nov. 15, 2023, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it had approved…
Mule deer tested positive for chronic wasting disease in Yellowstone National Park
On Nov. 14, 2023, Yellowstone National Park and the Wyoming Game and Fish Department (WGFD) confirmed the presence…
JAMA reported widening gender gap in life expectancy in the U.S. due to COVID-19
On Nov. 13, 2023, the Journal JAMA reported evidence that showed COVID-19 had widened the gendered life expectancy…
The White House lanuched Initiative on Women’s Health Research
On Nov. 13, 2023, the White House announced the first-ever Initiative on Womenï¾’s Health Research, an effort led…
USDA researchers confirmed six unique strains of African Swine fever virus
On Nov. 13, 2023, the U.S. Department of Department of Agriculture (USDA) announced that researchers have reclassified the…
Surgeons in New York announced world’s first eye transplant
On Nov. 10, 2023, surgeons in New York announced they had performed the first-ever whole-eye transplant in a…
CDC published first preliminary in-season flu burden estimates
On Nov. 10, 2023, the CDC estimated that from Oct. 1, 2023, through Nov. 11, 2023, there were…
FDA approved first vaccine to prevent disease caused by chikungunya virus
On Nov. 9, 2023, the U.S. Food and Drug Administration approved Valneva’s Ixchiq, the first chikungunya vaccine. Ixchiq…
FDA approved first treatment for patients with rare inherited blood clotting disorder
On Nov. 9, 2023, the U.S. Food and Drug Administration approved ‘ Takeda PharmaceuticalsVAdzynma, the first recombinant (genetically…
FDA cleared first COVID-19 home antigen test
On Nov. 9, 2023, the U.S. Food and Drug Administration cleared for marketing the first over-the-counter (OTC) antigen…
Monica Bertagnolli, M.D. took the helm at National Institutes of Health
On Nov. 9, 2023, the National Institute of health (NIH) announced that Monica M. Bertagnolli, M.D., had begun…
FDA approved new medication for chronic weight management
On Nov. 8, 2023, the U.S. Food and Drug Administration approved Eli Lilly’s Zepbound (tirzepatide) injection for chronic…
WHO launched guide on whole genome sequencing use as a tool for foodborne disease surveillance and response
On Nov. 7, 2023, the World Health Organization (WHO) announced that it had released a new guidance: ﾓWhole…
Rolls-Royce joined Boeing and World Energy for successful 100% sustainable aviation fuel flight
On Nov. 7, 2023, Rolls-Royce, working with Boeing and World Energy, announced that it had carried out a…
CDC expanded testing of international air traveler samples to include flu RSV, and other respiratory viruses
On Nov. 6, 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced that it was conducting…
Nearly 1 million chickens killed on a Minnesota farm because of bird flu
On Nov. 6, 2023, the U.S. Department of Agricultureï¾’s (USDA) announced that nearly 1 million chickens on a…
First human-like COVID-19 mouse model created
On Nov. 6, 2023, researchers at NYU Grossman School of Medicine announced they had engineered the first mice…
Abbott received FDA approval for HPV test to run on Alinity m family of diagnostic assays
On Nov. 2, 2023, Abbott announced that it had received U.S. Food and Drug Administration (FDA) approval for…
International Health Regulations National Focal Point of Zambia notified WHO of an anthrax outbreak in humans
On Nov. 1, 2023, the International Health Regulations (IHR) National Focal Point of Zambia notified WHO of an…
FDA approved Novartis Cosentyx as the first new biologic treatment for hidradenitis suppurativa patients in a decade
On Oct. 31, 2023, Novartis announced that the US Food and Drug Administration (FDA) had approved Cosentyxï¾® (secukinumab)…
Novavax’s updated COVID-19 vaccine approved in the EU
On Oct. 31, 2023, Novavax announced that the European Commission had granted approval for Nuvaxovidï¾™ XBB.1.5 dispersion for…
FDA approved interchangeable biosimilar for multiple inflammatory diseases
On Oct. 31, 2023, the U.S. Food and Drug Administration announced it had approved Amgen’s Wezlana (ustekinumab-auub) as…
First locally acquired case of dengue in California detected in a Pasadena resident
On Oct. 30, 2023,California Department of Public Health reported The first locally acquired case of dengue in California…
Biotechnology | Diagnostics | Life Science News | Medical Device | Neurology | Non-Profit Research | Stem Cell | Therapeutics
California’s Stem Cell Agency invested more than $42.1 million in translational-stage research
On Oct. 27, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $42.1 million to fund various translational…
Biological fingerprints in soil showed where diamond-containing ore is buried
On Oct. 25, 2023, University of British Columbia researchers announced they had identified buried kimberlite, the rocky home…
Bavarian Nordicï¾’s Mpox vaccine received recommendation from U.S. CDC Advisory Committee for routine use in adults at risk
On Oct. 25, 2023, Bavarian Nordic announced that the U.S. Centers for Disease Control and Preventionï¾’s (CDC) Advisory…
FDA approved new therapy for rare form of blood cancers called myelodysplastic syndromes
On Oct. 24, 2023, the U.S. Food and Drug Administration approved Servier Pharmaceuticals’ Tibsovo (ivosidenib) for the treatment…
Highly pathogenic avian influenza confirmed on Bird Island, South Georgia – the first known cases in Antarctic
On Oct. 23, 2023, the British Antarctic Survey (BAS) reported that Highly Pathogenic Avian Influenza (HPAI) had been…
U.S. CDC reported high rates of child flu hospitalizations recorded in 2022-2023 season
On Oct. 20, 2023, the U.S. Centers for Disease Control and Prevention (CDC) reported that among children and…
FDA approved PENBRAYA,the first and only vaccine for prevention of most common serogroups causing meningococcal
On Oct. 20, 2023, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved PENBRAYA (meningococcal…